Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase

被引:17
作者
Oladimeji, Peter O. [1 ]
Lin, Wenwei [1 ]
Brewer, C. Trent [1 ,2 ]
Chen, Taosheng [1 ,2 ]
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
美国国家卫生研究院;
关键词
CONSTITUTIVE ANDROSTANE RECEPTOR; DRUG-METABOLISM; NUCLEAR RECEPTORS; GENE-EXPRESSION; CELL-DEATH; PXR; RESISTANCE; INHIBITORS; METFORMIN; APOPTOSIS;
D O I
10.1038/srep46751
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pregnane X receptor (PXR) is a xenobiotic receptor that regulates the detoxification and clearance of drugs and foreign compounds from the liver. There has been mounting evidence of crosstalk between the drug metabolism pathway and the energy metabolism pathway, but little is known about this cross-regulation. To further delineate the energy metabolism and drug metabolism crosstalk in this study, we exposed HepG2 cells to varying glucose concentrations. We observed that PXR activity was induced under high-glucose conditions. This finding is consistent with previous clinical reports of increased drug clearance in patients with untreated diabetes. We demonstrated that AMP-activated protein kinase (AMPK) modulates PXR transcriptional activity and that pharmacologically manipulated AMPK activation exhibits an inverse relation to PXR activity. Activation of AMPK was shown to downregulate PXR activity and, consistent with that, potentiate the response of cells to the drug. Taken together, our results delineate a hitherto unreported axis of regulation that involves the energy status of the cell, PXR regulation, and drug sensitivity.
引用
收藏
页数:15
相关论文
共 66 条
[1]   ENHANCEMENT OF ANTITUMOR-ACTIVITY OF MITOMYCIN-C INVITRO AND INVIVO BY UCN-01, A SELECTIVE INHIBITOR OF PROTEIN-KINASE-C [J].
AKINAGA, S ;
NOMURA, K ;
GOMI, K ;
OKABE, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (03) :183-189
[2]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[3]   Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells [J].
Boergermann, J. H. ;
Kopf, J. ;
Yu, P. B. ;
Knaus, P. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (11) :1802-1807
[4]   Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond [J].
Chai, Xiaojuan ;
Zeng, Su ;
Xie, Wen .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (03) :253-266
[5]   Regulation of drug resistance by human pregnane X receptor in breast cancer [J].
Chen, Yakun ;
Tang, Yong ;
Chen, Shuqing ;
Nie, Daotai .
CANCER BIOLOGY & THERAPY, 2009, 8 (13) :1265-1272
[6]   Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome [J].
Cool, Barbara ;
Zinker, Bradley ;
Chiou, William ;
Kifle, Lemma ;
Cao, Ning ;
Perham, Matthew ;
Dickinson, Robert ;
Adler, Andrew ;
Gagne, Gerard ;
Iyengar, Rajesh ;
Zhao, Gang ;
Marsh, Kennan ;
Kym, Philip ;
Jung, Paul ;
Camp, Heidi S. ;
Frevert, Ernst .
CELL METABOLISM, 2006, 3 (06) :403-416
[7]  
CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x
[8]   Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes [J].
Davidson, Matthew D. ;
Ballinger, Kimberly R. ;
Khetani, Salman R. .
SCIENTIFIC REPORTS, 2016, 6
[9]  
Duan ZF, 2004, MOL CANCER THER, V3, P833
[10]   Chemoprevention Meets Glucose Control [J].
Engelman, Jeffrey A. ;
Cantley, Lewis C. .
CANCER PREVENTION RESEARCH, 2010, 3 (09) :1049-1052